Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01454947 · ClinicalTrials.gov registry record · NA
Use of Behavioral Economics to Improve Treatment of Acute Respiratory Infections (Main Study)
A NA study of Acute Respiratory Infections (ARIs), sponsored by University of Southern California.
- Completed
- Registry status
- NA
- Development phase
- 248
- Enrollment target
- 20
- Study locations
NCT01454947: Completed NA study of Acute Respiratory Infections (ARIs), sponsored by University of Southern California.
NCT01454947 is a NA study of Acute Respiratory Infections (ARIs) that has completed, run by University of Southern California. The registered enrollment target is 248 participants, below the 281-participant average among 3 other Acute Respiratory Infections (ARIs) trials with a reported enrollment target (12% lower). The trial reports 20 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01454947, a NA study of Acute Respiratory Infections (ARIs), has completed, sponsored by University of Southern California.
- COMPLETED
- Registry status
- NA
- Development phase
- 248 participants
- Enrollment target
- 20
- Study locations
Study Summary
Bacteria resistant to antibiotic therapy are a major public health problem. The evolution of multi-drug resistant pathogens may be encouraged by provider prescribing behavior. Inappropriate use of antibiotics for nonbacterial infections and overuse of broad spectrum antibiotics can lead to the development of resistant strains. Though providers are adequately trained to know when antibiotics are and are not comparatively effective, this has not been sufficient to affect critical provider practices. The intent of this study is to apply behavioral economic theory to reduce the rate of antibiotic prescriptions for acute respiratory diagnoses for which guidelines do not call for antibiotics. Specifically targeted are infections that are likely to be viral. The objective of this study is to improve provider decisions around treatment of acute respiratory infections. The participants are practicing attending physicians or advanced practice nurses (i.e. providers) at participating clinics who see acute respiratory infection patients. A maximum of 550 participants will be recruited for this study. Providers consenting to participate will fill out a baseline questionnaire online. Subsequent to baseline data collection and enrollment, participating clinic sites will be randomized to the study arms, as described below. There will be a control arm, with clinic sites randomized in a multifactorial design to up to three interventions that leverage the electronic medical record: Order Sets that are triggered by electronic health record (EHR) workflow containing exclusively guideline concordant choices (SA, for Suggested Alternatives); Accountable Justifications triggered by discordant prescriptions that populate the note with provider's rationale for guideline exceptions (AJ); and performance feedback that benchmarks providers' own performance to that of their peers (PC, for Peer Comparisons). The outcomes of interest are antibiotic prescribing patterns, including prescribing
Primary Outcome
Assess inappropriate antibiotic prescribing rates (relative to all practices that did not receive the intervention) for antibiotic-inappropriate acute respiratory tract infection visits and no concomitant reason for antibiotic prescribing. based on the following non-antibiotic-appropriate International Statistical Classification of Diseases, version 9 (ICD-9) diagnoses: 460 Acute nasopharyngitis (common cold) 465 Acute laryngopharyngitis/acute upper respiratory infection 466 Acute bronchitis
Conditions Studied
Interventions
- BEHAVIORAL Clinical Decision Support (CDS): Accountable Justifications
- BEHAVIORAL Audit and Feedback: Peer Comparison
- BEHAVIORAL CDS Order Sets: Suggested Alternatives
Study Locations (20)
California
- Altamed Anaheim Lincoln - Anaheim
- Altamed Anaheim West - Anaheim
- Altamed Bell Clinic - Bell
- Altamed Mobile Unit Primary Care - Commerce
- Altamed DVL El Monte - El Monte
- Altamed El Monte Clinic - El Monte
- Altamed Garden Grove Harbor - Garden Grove
- Altamed Huntington Beach Clinic - Huntington Beach
- Altamed PACE Rugby - Huntington Park
- The Children's Clinic Family Health Center at Cesar Chavez Elementary School - Long Beach
- The Children's Clinic Family Health Center at Hamilton Middle School - Long Beach
- The S. Mark Taper Foundation Children's Clinic Family Health Center - Long Beach
- The Children's Clinic at the Long Beach Multi-Service Center for the Homeless - Long Beach
- The Vasek Polak Children's Clinic Family Health Center - Long Beach
- Altamed PACE Grand Plaza - Los Angeles
- Altamed William Mead Homes - Los Angeles
- Altamed Commerce Clinic - Los Angeles
- Altamed DVL Commerce - Los Angeles
- Altamed PACE Pomona - Los Angeles
- Altamed Boyle Heights Clinic - Los Angeles
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 248 participants |
| Start Date | 2011-08 |
| Est. Completion | 2014-09 |
| Phase | NA |
What the finished NCT01454947 record still lists
NCT01454947 is an interventional study that assigns participants to a tested intervention. The registered 248 participants enrollment target is mid-sized for trials with a published cap, below the 281-participant average among 3 other Acute Respiratory Infections (ARIs) trials with a reported enrollment target (12% lower).
The record links to 1 condition, with Acute Respiratory Infections (ARIs) appearing as the primary indexed condition, and to 3 interventions - of which Clinical Decision Support (CDS): Accountable Justifications is the first listed.
NCT01454947 names 20 study sites across 1 states, led by California.
Frequently Asked Questions
What is clinical trial NCT01454947 about?
NCT01454947 is a clinical study titled "Use of Behavioral Economics to Improve Treatment of Acute Respiratory Infections (Main Study)". Bacteria resistant to antibiotic therapy are a major public health problem. The evolution of multi-drug resistant pathogens may be encouraged by provider prescribing behavior. Inappropriate use of antibiotics for nonbacterial infections and overuse of broad spectrum antibiotics can lead to the devel...
What is the current status of trial NCT01454947?
This trial is currently completed. It is a NA study. The enrollment target is 248 participants. The study started on 2011-08. Estimated completion is 2014-09.
What conditions does trial NCT01454947 study?
This clinical trial studies the following conditions: Acute Respiratory Infections (ARIs).
What interventions are being tested in trial NCT01454947?
The interventions under investigation include: Clinical Decision Support (CDS): Accountable Justifications (BEHAVIORAL), Audit and Feedback: Peer Comparison (BEHAVIORAL), CDS Order Sets: Suggested Alternatives (BEHAVIORAL).
Who is sponsoring clinical trial NCT01454947?
This trial is sponsored by University of Southern California, which has 617 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01454947 being conducted?
This trial has 20 study locations across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Acute Respiratory Infections (ARIs)
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04577911 · 248 participants
How is Social Connection Represented in the Brain?
- NCT04777994 · 248 participants · Phase 1
Study With ABBV-CLS-484 in Participants With Locally Advanced or Metastatic Tumors
- NCT04792489 · 248 participants · Phase 2
DALY II USA/ MB-CART2019.1 for DLBCL
- NCT04830137 · 248 participants · Phase 1
A Study of NX-2127 in Adults With Relapsed/Refractory B-cell Malignancies
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia